Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

NOAH clarifies critically important antibiotics
Antibiotics
"All classes of antibiotics, whether critically important or not, should be used responsibly" - Donal Murphy, NOAH.
Document divides antimicrobials into risk categories

A document to clarify which antibiotics should be considered as critically important has been published by the National Office of Animal Health (NOAH).

The document comes after an assessment by the European Medicines Agency (EMA) and aims to clear up any confusion about which antibiotics should be considered in this group.

Carried out by the Antimicrobial Advice Ad Hoc Expert Group (AMEG), the work has resulted in the further categorisation of critically important antibiotics (CIAs) into risk categories.

Category one contains antimicrobials that are considered a low or limited risk to public health. It includes macrolides, certain penicillins and tetracyclines. NOAH states that these ‘should be used with current responsible use practices to keep their risk low’.

Category two contains antimicrobials that are considered a high risk to public health. This includes fluroquinolones, 3rd and 4th generation cephalosporins and colistin. NOAH adds that these antimicrobials ‘should only be used when there are no alternative antimicrobials authorised for the respected target species and indication’.

“NOAH believes the classification and use of antibiotics in veterinary medicine should be driven and guided by the regulators, who are independent and make science based decisions and recommendations,” said Donal Murphy, head of technical and regulatory affairs at NOAH.

“Of course, all classes of antibiotics, whether critically important or not, should be used responsibly and guided by the principle outlined by the Responsible Use of Medicines in Agriculture Alliance (RUMA) who state they should be used ‘as little as possible but as much as necessary’.

“The use of these important products in this manner can ensure that the availability and efficacy of antibiotics can be maintained to ensure animal health and welfare in the future,” he adds.

To view the document and other NOAH briefing documents on antibiotics visit noah.co.uk.

Become a member or log in to add this story to your CPD history

Applications open for MMI research grants

News Story 1
 RCVS' Mind Matters Initiative (MMI) has launched round two of its veterinary mental health research grants.

Researchers have until 11.59pm on Wednesday, 28 May 2025 to apply for a grant for research which reflects MMI's 2025 focus areas.

Only one Impact Grant was awarded last year, and so this year there are two Discovery Grants and one Impact Grants available. Each Discovery Grant is worth £5,000 and the Impact Grant is worth £15,000.

For more information or to apply, email researchgrants@rcvs.org.uk to contact the MMI team.

 

Click here for more...
News Shorts
BBC Radio 4 documentary addresses corporate fees

BBC Radio 4's File on 4 Investigates has released a documentary exploring how corporate-owned veterinary practices may be inflating bills to increase profit.

Released on 15 April, 'What's Happening To Your Vet Bills?' revealed the policies which many corporate groups have in place to increase their profits. This included targets and upgrades which veterinary teams are tasked with meeting on a regular basis.

It also features Anrich Vets, an independently-owned practice based in Wigan. Following the case of Staffordshire terrier Benjy, who is diagnosed with a tumour, the documentary shares how the team were able to offer contextualised care and advice to make the procedure as affordable as possible for his owners.

The documentary can be heard on demand on BBC iPlayer.